South Korea Orthobiologics Market Size, Share, and COVID-19 Impact Analysis, By Product (DBM, Allograft, BMP, and Visco supplementation), By Application (Spinal Fusion and Trauma Repair), and South Korea Orthobiologics Market Industry Trend, Forecasts to 2035

South Korea Orthobiologics Market Size Insights Forecasts to 2035

• The South Korea Orthobiologics Market Size Was Estimated at USD 89.54 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.46% from 2025 to 2035
• The South Korea Orthobiologics Market Size is Expected to Reach USD 197.57 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the South Korea Orthobiologics Market Size is anticipated to reach USD 197.57 million by 2035, growing at a CAGR of 7.46% from 2025 to 2035. The main reasons driving market expansion are the rise in sports injuries and traffic accidents, the use of minimally invasive therapies, the rising frequency of orthopedic surgeries, and an aging population.

Market Overview

The Orthobiologics market involves the development and use of biologically-based materials, such as bone grafts, growth factors, and cell-based therapies, to aid in the repair and regeneration of musculoskeletal tissues. These products offer significant benefits, including faster healing, reduced recovery time, and improved patient outcomes compared to traditional treatments. The growing prevalence of orthopedic conditions, aging populations, and advancements in regenerative medicine present vast opportunities for market growth. South Korea, support this sector through funding for research, regulatory frameworks, and healthcare infrastructure improvements. Initiatives aimed at promoting innovation and adoption of advanced therapies further boost the market, encouraging safer, more effective solutions for trauma repair, spinal fusion, and other orthopedic applications.

Report Coverage

This research report categorizes the market for South Korea Orthobiologics market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea orthobiologics market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea orthobiologics market.

Driving Factors

The increasing prevalence of orthopedic conditions, such as fractures and degenerative diseases, especially evident among the aging population. Advancements in regenerative medicine and biologic technologies have improved treatment outcomes, encouraging wider adoption. Additionally, the growing preference for minimally invasive surgeries that promote faster healing and reduced recovery time fuels demand.

Restraining Factors

The high treatment costs and limited reimbursement policies, which can restrict patient access. Additionally, the complexity of regulatory approval processes and stringent government regulations pose challenges for market entry and product development. Variability in product efficacy and concerns about potential side effects also limit widespread adoption.

Market Segmentation

The South Korea orthobiologics market share is classified into product and application.

• The DBM segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea orthobiologics market is segmented by product into DBM, allograft, BMP, and viscosupplementation. Among these, the DBM segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. Its effectiveness in bone regeneration and wide clinical applications in orthopedic surgeries. DBM is preferred for its osteoinductive properties, safety, and compatibility, making it a reliable alternative to autografts. Increasing orthopedic procedures, aging population, and rising awareness about minimally invasive treatments contribute to its growing demand.

• The spinal fusion segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea orthobiologics market is segmented by application into spinal fusion and trauma repair. Among these, the spinal fusion segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period. The rising prevalence of spinal disorders and increasing demand for advanced surgical treatments. Spinal fusion procedures benefit from orthobiologics like bone grafts that enhance healing and improve outcomes. Advances in minimally invasive techniques and a growing geriatric population further drive this trend.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea orthobiologics market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• OSTEOSYS Co., Ltd.
• CG Bio Inc.
• Woosam Medical
• T&L Co., Ltd.
• DUK-IN
• SeohanCare Co., Ltd.
• Solco Biomedical Co., Ltd.
• Taeyeon Medical
• TDM Co., Ltd.
• U&I Corporation
• INFINITT Healthcare
• Cybermed Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea orthobiologics market based on the below-mentioned segments:

South Korea Orthobiologics Market, By Product

• DBM
• Allograft
• BMP
• Viscosupplementation

South Korea Orthobiologics Market, By Application

• Spinal Fusion
• Trauma Repair